z-logo
Premium
Assessment of the 4‐factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study
Author(s) -
Morabito Fortunato,
Tripepi Giovanni,
Del Poeta Giovanni,
Mauro Francesca Romana,
Reda Gianluigi,
Sportoletti Paolo,
Laurenti Luca,
Coscia Marta,
Herishanu Yair,
Varettoni Marzia,
Murru Roberta,
Chiarenza Annalisa,
Visentin Andrea,
Condoluci Adalgisa,
Moia Riccardo,
Pietrasanta Daniela,
Loseto Giacomo,
Consoli Ugo,
Scortechini Ilaria,
Rossi Francesca Maria,
Zucchetto Antonella,
Vigna Ernesto,
Martino Enrica Antonia,
Mendicino Francesco,
Botta Cirino,
Caracciolo Daniele,
Cassin Ramona,
D'Arrigo Graziella,
Galimberti Sara,
Rago Angela,
Angeletti Ilaria,
Biagi Annalisa,
Del Giudice Ilaria,
Bomben Riccardo,
Neri Antonino,
Fronza Gilberto,
Cutrona Giovanna,
Rossi Davide,
Di Raimondo Francesco,
Cuneo Antonio,
Gaidano Gianluca,
Polliack Aaron,
Trentin Livio,
Foà Robin,
Ferrarini Manlio,
Gattei Valter,
Gentile Massimo
Publication year - 2021
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26127
Subject(s) - ibrutinib , medicine , oncology , chronic lymphocytic leukemia , leukemia

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here